Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Insulet Corporation

PODD
Current price
244.98 USD +7.63 USD (+3.21%)
Last closed 239.3 USD
ISIN US45784P1012
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 16 648 225 792 USD
Yield for 12 month +58.08 %
1Y
3Y
5Y
10Y
15Y
PODD
21.11.2021 - 28.11.2021

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Address: 100 Nagog Park, Acton, MA, United States, 01720

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

247.64 USD

P/E ratio

42.8592

Dividend Yield

Current Year

+1 697 100 000 USD

Last Year

+1 305 300 000 USD

Current Quarter

+488 500 000 USD

Last Quarter

+441 700 000 USD

Current Year

+1 159 900 000 USD

Last Year

+805 600 000 USD

Current Quarter

+334 200 000 USD

Last Quarter

+309 900 000 USD

Key Figures PODD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 364 000 000 USD
Operating Margin TTM 11.18 %
PE Ratio 42.8592
Return On Assets TTM 6.85 %
PEG Ratio 3.6457
Return On Equity TTM 50.93 %
Wall Street Target Price 247.64 USD
Revenue TTM 1 872 700 032 USD
Book Value 14.24 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 23.2 %
Dividend Yield
Gross Profit TTM 805 600 000 USD
Earnings per share 5.54 USD
Diluted Eps TTM 5.54 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 563.9 %
Profit Margin 21.11 %

Dividend Analytics PODD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PODD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation PODD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 42.8592
Forward PE 60.9756
Enterprise Value Revenue 9.1294
Price Sales TTM 8.89
Enterprise Value EBITDA 44.7792
Price Book MRQ 16.5464

Financials PODD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PODD

For 52 weeks

151.56 USD 243.98 USD
50 Day MA 226.74 USD
Shares Short Prior Month 2 987 331
200 Day MA 195.13 USD
Short Ratio 5.22
Shares Short 2 767 878
Short Percent 5.28 %